Search research articles
Contact Us
Filters
Showing results (151-160 of 214) with videos related to
Page
of 22
Sort By:
Pathogens & Immunity
|
May 15, 2024
Safety, Efficacy, and Pharmacokinetics of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies BMS-986414 (C135-LS) and BMS-986413 (C144-LS) Administered Subcutaneously in Non-Hospitalized Persons with COVID-19 in a Phase 2 Trial
Katya C Corado, Kara W Chew, Mark J Giganti, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 9, 2022
Nasal and Plasma Severe Acute Respiratory Syndrome Coronavirus 2 RNA Levels Are Associated With Timing of Symptom Resolution in the ACTIV-2 Trial of Nonhospitalized Adults With Coronavirus Disease 2019
Yijia Li, Linda J Harrison, Kara W Chew, et al.
The Journal of Infectious Diseases
|
June 6, 2018
Macrophage Activation Marker Soluble CD163 Is a Dynamic Marker of Liver Fibrogenesis in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection
Anna Lidofsky, Jacinta A Holmes, Eoin R Feeney, et al.
Pathogens & Immunity
|
September 9, 2024
Impact of SARS-CoV-2 Resistance to Antiviral Monoclonal Antibody Therapy on Neutralizing Antibody Response
Marc-Kendy Paul, Manish C Choudhary, Amy L Heaps, et al.
Eclinicalmedicine
|
October 19, 2023
Safety and efficacy of inhaled interferon-β1a (SNG001) in adults with mild-to-moderate COVID-19: a randomized, controlled, phase II trial
Prasanna Jagannathan, Kara W Chew, Mark J Giganti, et al.
Open Forum Infectious Diseases
|
December 5, 2022
Predictors of SARS-CoV-2 RNA From Nasopharyngeal Swabs and Concordance With Other Compartments in Nonhospitalized Adults With Mild to Moderate COVID-19
Carlee Moser, Jonathan Z Li, Joseph J Eron, et al.
Biorxiv : the Preprint Server for Biology
|
December 4, 2023
SARS-CoV-2 monoclonal antibody treatment followed by vaccination shifts human memory B cell epitope recognition suggesting antibody feedback
Camila H Coelho, Nathaniel Bloom, Sydney I Ramirez, et al.
JCI Insight
|
November 15, 2022
Bamlanivimab therapy for acute COVID-19 does not blunt SARS-CoV-2-specific memory T cell responses
Sydney I Ramirez, Alba Grifoni, Daniela Weiskopf, et al.
The Journal of Infectious Diseases
|
January 20, 2023
Phase 2 Safety and Antiviral Activity of SAB-185, a Novel Polyclonal Antibody Therapy for Nonhospitalized Adults With COVID-19
Babafemi O Taiwo, Kara W Chew, Carlee Moser, et al.
The Journal of Infectious Diseases
|
August 31, 2023
Variant-Specific Viral Kinetics in Acute COVID-19
Ruy M Ribeiro, Manish C Choudhary, Rinki Deo, et al.
Page
of 22
Search research articles
Search
Showing results (151-160 of 214) with videos related to
Sort By:
Page
of 22
Pathogens & Immunity
|
May 15, 2024
Safety, Efficacy, and Pharmacokinetics of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies BMS-986414 (C135-LS) and BMS-986413 (C144-LS) Administered Subcutaneously in Non-Hospitalized Persons with COVID-19 in a Phase 2 Trial
Katya C Corado, Kara W Chew, Mark J Giganti, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 9, 2022
Nasal and Plasma Severe Acute Respiratory Syndrome Coronavirus 2 RNA Levels Are Associated With Timing of Symptom Resolution in the ACTIV-2 Trial of Nonhospitalized Adults With Coronavirus Disease 2019
Yijia Li, Linda J Harrison, Kara W Chew, et al.
The Journal of Infectious Diseases
|
June 6, 2018
Macrophage Activation Marker Soluble CD163 Is a Dynamic Marker of Liver Fibrogenesis in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection
Anna Lidofsky, Jacinta A Holmes, Eoin R Feeney, et al.
Pathogens & Immunity
|
September 9, 2024
Impact of SARS-CoV-2 Resistance to Antiviral Monoclonal Antibody Therapy on Neutralizing Antibody Response
Marc-Kendy Paul, Manish C Choudhary, Amy L Heaps, et al.
Eclinicalmedicine
|
October 19, 2023
Safety and efficacy of inhaled interferon-β1a (SNG001) in adults with mild-to-moderate COVID-19: a randomized, controlled, phase II trial
Prasanna Jagannathan, Kara W Chew, Mark J Giganti, et al.
Open Forum Infectious Diseases
|
December 5, 2022
Predictors of SARS-CoV-2 RNA From Nasopharyngeal Swabs and Concordance With Other Compartments in Nonhospitalized Adults With Mild to Moderate COVID-19
Carlee Moser, Jonathan Z Li, Joseph J Eron, et al.
Biorxiv : the Preprint Server for Biology
|
December 4, 2023
SARS-CoV-2 monoclonal antibody treatment followed by vaccination shifts human memory B cell epitope recognition suggesting antibody feedback
Camila H Coelho, Nathaniel Bloom, Sydney I Ramirez, et al.
JCI Insight
|
November 15, 2022
Bamlanivimab therapy for acute COVID-19 does not blunt SARS-CoV-2-specific memory T cell responses
Sydney I Ramirez, Alba Grifoni, Daniela Weiskopf, et al.
The Journal of Infectious Diseases
|
January 20, 2023
Phase 2 Safety and Antiviral Activity of SAB-185, a Novel Polyclonal Antibody Therapy for Nonhospitalized Adults With COVID-19
Babafemi O Taiwo, Kara W Chew, Carlee Moser, et al.
The Journal of Infectious Diseases
|
August 31, 2023
Variant-Specific Viral Kinetics in Acute COVID-19
Ruy M Ribeiro, Manish C Choudhary, Rinki Deo, et al.
Page
of 22